Yale Jen
Stock Analyst at Laidlaw & Co.
(0.79)
# 3,944
Out of 5,012 analysts
14
Total ratings
14.29%
Success rate
-7.07%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Yale Jen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSRX Nasus Pharma | Initiates: Buy | $22 | $7.21 | +205.13% | 1 | Sep 29, 2025 | |
| SNTI Senti Biosciences | Initiates: Buy | $5 | $1.74 | +187.36% | 1 | Jun 6, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $75 → $105 | $62.11 | +69.05% | 2 | Mar 27, 2025 | |
| NVCT Nuvectis Pharma | Initiates: Buy | $19 | $6.11 | +210.97% | 1 | Mar 17, 2025 | |
| LFWD Lifeward | Initiates: Buy | $10 | $0.79 | +1,161.03% | 1 | Feb 10, 2025 | |
| ABVX ABIVAX Société Anonyme | Initiates: Buy | $48 | $87.01 | -44.83% | 1 | Jul 29, 2024 | |
| PHGE BiomX | Initiates: Buy | $25 | $0.57 | +4,293.67% | 1 | May 28, 2024 | |
| INAB IN8bio | Initiates: Buy | $225 | $2.46 | +9,046.34% | 1 | Mar 18, 2024 | |
| CING Cingulate | Downgrades: Hold | n/a | $4.15 | - | 2 | Dec 22, 2023 | |
| SILO Silo Pharma | Initiates: Buy | $10 | $0.70 | +1,323.28% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.94 | - | 1 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $240 | $1.86 | +12,803.23% | 1 | Sep 6, 2022 |
Nasus Pharma
Sep 29, 2025
Initiates: Buy
Price Target: $22
Current: $7.21
Upside: +205.13%
Senti Biosciences
Jun 6, 2025
Initiates: Buy
Price Target: $5
Current: $1.74
Upside: +187.36%
Soleno Therapeutics
Mar 27, 2025
Maintains: Buy
Price Target: $75 → $105
Current: $62.11
Upside: +69.05%
Nuvectis Pharma
Mar 17, 2025
Initiates: Buy
Price Target: $19
Current: $6.11
Upside: +210.97%
Lifeward
Feb 10, 2025
Initiates: Buy
Price Target: $10
Current: $0.79
Upside: +1,161.03%
ABIVAX Société Anonyme
Jul 29, 2024
Initiates: Buy
Price Target: $48
Current: $87.01
Upside: -44.83%
BiomX
May 28, 2024
Initiates: Buy
Price Target: $25
Current: $0.57
Upside: +4,293.67%
IN8bio
Mar 18, 2024
Initiates: Buy
Price Target: $225
Current: $2.46
Upside: +9,046.34%
Cingulate
Dec 22, 2023
Downgrades: Hold
Price Target: n/a
Current: $4.15
Upside: -
Silo Pharma
Aug 28, 2023
Initiates: Buy
Price Target: $10
Current: $0.70
Upside: +1,323.28%
Aug 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.94
Upside: -
Sep 6, 2022
Initiates: Buy
Price Target: $240
Current: $1.86
Upside: +12,803.23%